Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis. Quistrebert, Jocelyn; Hässler, Signe; Bachelet, Delphine; Mbogning, Cyprien; Musters, Anne; Tak, Paul Peter; Wijbrandts, Carla Ann; Herenius, Marieke; Bergstra, Sytske Anne; Akdemir, Gülşah; Johannesson, Martina; Combe, Bernard; Fautrel, Bruno; Chollet-Martin, Sylvie; Gleizes, Aude; Donnellan, Naoimh; Deisenhammer, Florian; Davidson, Julie; Hincelin-Mery, Agnès; Dönnes, Pierre; Fogdell-Hahn, Anna; De Vries, Niek; Huizinga, Tom; Abugessaisa, Imad; Saevarsdottir, Saedis; Hacein-Bey-Abina, Salima; Pallardy, Marc; Broët, Philippe; Mariette, Xavier; ABIRISK Consortium. Seminars in Arthritis and Rheumatism. 2019; 48: p.967-975. doi:10.1016/j.semarthrit.2018.10.006Article
Biostatistique en grande dimension